Effects of Losartan on Renal Tubular Epithelial Cells Transdifferentiation in Streptozotocin-induced Diabetic Rats
Jian-ping Ning
Abstract
Jian-ping Ning
Abstract
Objective To observe the renal tubular epithelial cells transdifferentiation and the effects of Losartan on streptozotocin-induced diabetic rats,explore the renal protective mechanisms of ARB in DN.Methods Fifty Wistar rats were randomly divided into three groups:(1) Normal control group without streptozotocin-induced diabetes and without therapy(n=10);(2)diabetes without therapy group(n=20),(3)diabetes therapy group with Losartan 20 mg/Kg ·d~(-1)(n=20);Rat models of diabetic mellitus were established by intraperitoneal injection of 60 mg/kg streptozotocin.At sixteen weeks after therapy with Lorsartan,The alpha smooth muscle actin(α-SMA),vimentin and transforming growth factor-β1(TGF-β1)in renal tubular epithelial cells were detected by immunohistochemistry of SP method.Results The positive areas of α-SMA,vimentin and TGF-β1 in renal tubular epithelial cells of diabetic group were 0.3690±0.0587,0.1546±0.0141 and 0.3716±0.0657 respectively,showed stronger passivity in comparison with Lorsartan therapy group(P0.01).Conclusion Losartan can down-regulate expression of α-SMA,vimentin and TGF-β1 in diabetic renal tubular epithelial cells,restrain the process of epithelial myfibroblast transdifferentiation in diabetic rats.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the renal tubular epithelial cells transdifferentiation and the effects of Losartan on streptozotocin-induced diabetic rats,explore the renal protective mechanisms of ARB in DN.Methods Fifty Wistar rats were randomly divided into three groups:(1) Normal control group without streptozotocin-induced diabetes and without therapy(n=10);(2)diabetes without therapy group(n=20),(3)diabetes therapy group with Losartan 20 mg/Kg ·d~(-1)(n=20);Rat models of diabetic mellitus were established by intraperitoneal injection of 60 mg/kg streptozotocin.At sixteen weeks after therapy with Lorsartan,The alpha smooth muscle actin(α-SMA),vimentin and transforming growth factor-β1(TGF-β1)in renal tubular epithelial cells were detected by immunohistochemistry of SP method.Results The positive areas of α-SMA,vimentin and TGF-β1 in renal tubular epithelial cells of diabetic group were 0.3690±0.0587,0.1546±0.0141 and 0.3716±0.0657 respectively,showed stronger passivity in comparison with Lorsartan therapy group(P0.01).Conclusion Losartan can down-regulate expression of α-SMA,vimentin and TGF-β1 in diabetic renal tubular epithelial cells,restrain the process of epithelial myfibroblast transdifferentiation in diabetic rats.
Key concepts: Streptozotocin, Transdifferentiation, Losartan, Diabetes mellitus, Endocrinology, Internal medicine, Medicine, Intraperitoneal injection